USPTO 2015–2025 USPTO PatentsView US Corporation

Express Scripts Strategic Development, Inc.

USPTO PatentsView assignee record - 324 granted patents across 55 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

324

Total patents granted

CPC technology areas

17.9

Avg claims per patent

+536%

5-year filing velocity

The verdict

Express holds 324 US patents across 55 technology areas, rank #1,307 of 50,000 tracked assignees.

#1,307
of 50,000 US assignees by volume: Top 1%
by Innovation Score (68.4/100): 17.9
avg claims per patent: +536%
filing velocity, last 5 yrs

Portfolio overview

Express Scripts Strategic Development, Inc. has been granted 324 US utility patents between 2017 and 2025, placing Express Scripts Strategic Development, Inc. at rank #1,307 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Express Scripts Strategic Development, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Express sits between Chugai Seiyaku Kabushiki Kaisha (325 patents, rank #1,303) and Virginia TECH Intellectual Properties, Inc. (324 patents, rank #1,311) - the closest US assignees by grant volume. The composite Innovation Score of 68.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 280 grants, compared with 44 in the 2015–2019 window, a +536% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Express Scripts Strategic Development, Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Express Scripts Strategic Development, Inc. against peers pursuing similar technology classes.

Chugai Seiyaku

325
Continental Reife…

325
Sony Interactive…

325
Ablic

324
PFU

324
The Hong Kong Uni…

324
UAB 360 IT

324
Virginia TECH Int…

324
Express Scripts S… ◀

324

What this shows Express holds 324 patents at rank #1,307, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Express

By rank, the assignees closest to #1,307 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Express's primary technology class.

Express's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

68 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Express Scripts Strategic Development, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	0.3%
2018	19	5.9%
2019	24	7.4%
2020	39	12.0%
2021	32	9.9%
2022	63	19.4%
2023	68	21.0%
2024	49	15.1%
2025	29	9.0%

Which technologies does Express Scripts Strategic Development, Inc. patent most?

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 157

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 131

G06F - ELECTRIC DIGITAL DATA PROCESSING 96

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 56

B65B - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 49

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 40

B65G - TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS 35

G07F - COIN-FREED OR LIKE APPARATUS 30

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 22

G10L - SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING 18

H04M - TELEPHONIC COMMUNICATION 18

G06K - GRAPHICAL DATA READING ; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 16

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 14

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 14

B64U - UNMANNED AERIAL VEHICLES [UAV]; EQUIPMENT THEREFOR 14

Top 15 of 55 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#1,307

Across all tracked assignees

Innovation Score

68.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Express Scripts Strategic Development, Inc. hold?

Express Scripts Strategic Development, Inc. holds 324 US granted patents filed between 2017 and 2025, spanning 55 technology areas.

What is Express Scripts Strategic Development, Inc.'s Innovation Score?

Express Scripts Strategic Development, Inc. has an Innovation Score of 68.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Express Scripts Strategic Development, Inc. focus on?

Express Scripts Strategic Development, Inc.'s top technology area is G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA) with 157 patents. The company has filed patents in 55 CPC subclasses total.

Is Express Scripts Strategic Development, Inc.'s patent filing rate increasing or decreasing?

Express Scripts Strategic Development, Inc.'s recent filing velocity is +536% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Express Scripts Strategic Development, Inc.'s patents?

Express Scripts Strategic Development, Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Express Scripts Strategic Development, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Express's 324 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Express ranks #1,307 of 50,000. Top 50 holders
Most of this portfolio concentrates in G16H - see who else leads that technology area. G16H leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.